Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Change in Receivables (2016 - 2017)

Armata Pharmaceuticals' Change in Receivables history spans 5 years, with the latest figure at -$2000.0 for Q2 2017.

  • For Q2 2017, Change in Receivables fell 150.0% year-over-year to -$2000.0; the TTM value through Sep 2017 reached -$11000.0, up 94.53%, while the annual FY2020 figure was $467000.0, N/A changed from the prior year.
  • Change in Receivables for Q2 2017 was -$2000.0 at Armata Pharmaceuticals, up from -$10000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $129000.0 in Q2 2013 and bottomed at -$140000.0 in Q4 2013.
  • The 5-year median for Change in Receivables is $1000.0 (2016), against an average of -$9000.0.
  • The largest annual shift saw Change in Receivables surged 152.14% in 2014 before it plummeted 2600.0% in 2015.
  • A 5-year view of Change in Receivables shows it stood at -$140000.0 in 2013, then soared by 152.14% to $73000.0 in 2014, then tumbled by 236.99% to -$100000.0 in 2015, then soared by 101.0% to $1000.0 in 2016, then plummeted by 300.0% to -$2000.0 in 2017.
  • Per Business Quant, the three most recent readings for ARMP's Change in Receivables are -$2000.0 (Q2 2017), -$10000.0 (Q1 2017), and $1000.0 (Q4 2016).